UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways

Frontiers in oncology, 2024-01, Vol.13, p.1322204-1322204

2024

Volltextzugriff (PDF)

Prognostic value of dysadherin in cancer: A systematic review and meta-analysis

Frontiers in oncology, 2022-09, Vol.12, p.945992

2022

Volltextzugriff (PDF)

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways

Frontiers in oncology, 2019-12, Vol.9, p.1306

2019

Volltextzugriff (PDF)

Displacement of Native FXYD Protein From Na + /K + -ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity

Frontiers in oncology, 2022-03, Vol.12, p.859216-859216

2022

Volltextzugriff (PDF)

A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody

Glycobiology (Oxford), 2019-04, Vol.29 (4), p.307-319

2019

Volltextzugriff (PDF)

High-Intensity Training Represses FXYD5 and Glycosylates Na,K-ATPase in Type II Muscle Fibres, Which Are Linked with Improved Muscle K + Handling and Performance

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5587

2023

Volltextzugriff (PDF)

The dysadherin/FAK axis promotes individual cell migration in colon cancer

International journal of biological sciences, 2024-01, Vol.20 (7), p.2356-2369

2024

Volltextzugriff (PDF)

Dysadherin awakens mechanical forces and promotes colorectal cancer progression

Theranostics, 2022-01, Vol.12 (9), p.4399-4414

2022

Volltextzugriff (PDF)

FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na + -K + -ATPase subunit in the 4T1 mouse breast cancer model

American Journal of Physiology: Cell Physiology, 2017-07, Vol.313 (1), p.C108-C117

2017

Volltextzugriff (PDF)

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma

Cancer management and research, 2020-01, Vol.12, p.221-232

2020

Volltextzugriff (PDF)

FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas

Cancer informatics, 2015-01, Vol.2015 (14), p.113-119

2015

Volltextzugriff (PDF)

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes

Oncotarget, 2017-04, Vol.8 (15), p.24457-24468

2017

Volltextzugriff (PDF)

Alterations in dysadherin expression and F-actin reorganization: a possible mechanism of hypericin-mediated photodynamic therapy in colon adenocarcinoma cells

Cytotechnology (Dordrecht), 2015-03, Vol.67 (2), p.311-330

2015

Volltextzugriff (PDF)

FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease

Frontiers in cell and developmental biology, 2016-03, Vol.4, p.26-26

Lubarski Gotliv, Irina

2016

Volltextzugriff (PDF)

Modulation of cell polarization by the Na+-K+-ATPase-associated protein FXYD5 (dysadherin)

American Journal of Physiology: Cell Physiology, 2014-06, Vol.306 (11), p.C1080-C1088

2014

Volltextzugriff (PDF)

Dysadherin: A new player in cancer progression

Cancer letters, 2007-10, Vol.255 (2), p.161-169

2007

Volltextzugriff (PDF)

Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells

International journal of cancer, 2012-01, Vol.130 (2), p.288-299

2012

Volltextzugriff (PDF)

Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells

Journal of hepatology, 2011-01, Vol.54 (1), p.122-131

2011

Volltextzugriff (PDF)

Dysadherin, A Cancer-Associated Cell Membrane Glycoprotein, Down-Regulates E-Cadherin and Promotes Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2002-01, Vol.99 (1), p.365-370

2002

Volltextzugriff (PDF)

Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells

Molecular medicine reports, 2015-11, Vol.12 (5), p.7239-7246

2015

Volltextzugriff (PDF)

Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion

Human pathology, 2011-04, Vol.42 (4), p.558-567

2011

Volltextzugriff (PDF)

Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites

Histology and histopathology, 2010-10, Vol.25 (10), p.1257

2010

Volltextzugriff (PDF)

Expression of dysadherin in the human male reproductive tract and in spermatozoa

Fertility and sterility, 2011-09, Vol.96 (3), p.554-561.e2

2011

Volltextzugriff (PDF)

Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer

Medical oncology (Northwood, London, England), 2012-09, Vol.29 (3), p.1463-1467

2012

Volltextzugriff (PDF)

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma

Cancer, 2005-04, Vol.103 (8), p.1693-1700

2005

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)
Buchkapitel
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Dysadherin
(43)
Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(33)
E-Cadherin
(21)
Oncology
(21)
Immunohistochemistry
(20)
Female
(19)
Male
(18)
Membrane Glycoproteins - Metabolism
(16)
Aged
(15)
Neoplasm Proteins - Metabolism
(15)
Prognosis
(15)
Tumors
(15)
Adult
(14)
Cadherins - Metabolism
(14)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Pathology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways

Prognostic value of dysadherin in cancer: A systematic review and meta-analysis

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways

Displacement of Native FXYD Protein From Na + /K + -ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity

A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody

High-Intensity Training Represses FXYD5 and Glycosylates Na,K-ATPase in Type II Muscle Fibres, Which Are Linked with Improved Muscle K + Handling and Performance

The dysadherin/FAK axis promotes individual cell migration in colon cancer

Dysadherin awakens mechanical forces and promotes colorectal cancer progression

FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na + -K + -ATPase subunit in the 4T1 mouse breast cancer model

Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma

FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes

Alterations in dysadherin expression and F-actin reorganization: a possible mechanism of hypericin-mediated photodynamic therapy in colon adenocarcinoma cells

FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease

Modulation of cell polarization by the Na+-K+-ATPase-associated protein FXYD5 (dysadherin)

Dysadherin: A new player in cancer progression

Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells

Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells

Dysadherin, A Cancer-Associated Cell Membrane Glycoprotein, Down-Regulates E-Cadherin and Promotes Metastasis

Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells

Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion

Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites

Expression of dysadherin in the human male reproductive tract and in spermatozoa

Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma

Suchergebnisse filtern